Article
Botulinum Neurotoxin A1 Signaling in Pain Modulation within Human Sensory Neurons
2025-06-24
Abstract excerpt
Botulinum neurotoxin type A1 (BoNT/A1) is an effective treatment for chronic migraine, but its direct mechanism of action on human sensory neurons has not been fully elucidated. While rodent studies on dorsal root ganglion (DRG) and trigeminal ganglion (TG) show that BoNT/A1 inhibits neurotransmission, including calcitonin gene-related peptide (CGRP) release, by cleaving SNAP-25, only one previous study has assess...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 5cb22839-6ed1-53c9-8924-399bac17d04b
- DOI
- 10.1101/2025.06.18.660472
